The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1013
ISSUE 1013
November 7, 1997
Issue 1013
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Mibefradil--A New Calcium-Channel Blocker
November 7, 1997 (Issue: 1013)
Mibefradil dihydrochloride (Posicor - Roche), a chemically distinct nondihydropyridine calcium-channel blocker, has been approved by the US Food and Drug Administration (FDA) and is being heavily promoted as the first T-type calcium-channel blocker...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.